Apex Biotechnology Corp.

NT$28.85As of Sun 8 Nov 2026, 12:00 UTC
TWSE:1733Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 0.61%
Div yield 4.51%
ROE 10.44%
Medical Devices
Beta (5Y) 0.28
PE TTM 15.27
TSR TTM (8.32%)
Mkt cap NT$2.884B
ROIC 12.47%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$31
9.13%
(58.55%)
Hold 7|11|7|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.31
0.34
0.35
0.35
17.99%
19.26%
14.43%
8.06%
RevenueNT$M
367.4
359.3
377.8
381.7
10.95%
7.19%
8.47%
8.47%
Peers (US$87.09M)
Cap (US$)
PE
96.84M
13.95x
83.85M
—
76.16M
23.43x
Capital
TTM
5Y
10Y
Leveragex
0.189
0.334
0.313
EBIT/Intx
0.482
0.269
0.224
Own earn%
(82.15)
134.80
140.95
Sh yield%
25.78
23.47
26.21
Owners
Insiders/Inst%
6.80
73.05
Short interest%
3.54
SBC / revenue%
1.28
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
9–13
$1 testx
0.0
Incr. ROIC%
4